The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis

Guideline Detail

September 2008

Retired guideline.

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer